A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
Recruiting · NCT07275840 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD | Neovascular Age-related Macular Degeneration | Recruiting | Phase 2 | 2026-01-08 | NCT07275840 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics Technology Limited (Shanghai R&D Center) | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai general hospital | Shanghai | China | 1 |